Blinatumomab - CaLiGraph

CaLiGraph

Property	Value
rdf:type	owl:NamedIndividual Therapeutic monoclonal antibody Monoclonal antibody for tumors Drug granted breakthrough therapy designation
rdfs:label	Blinatumomab
owl:sameAs	dbr:Blinatumomab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/List_of_drugs:_Bi%E2%80%93Bo http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies_for_tumors
skos:prefLabel	Blinatumomab
skos:altLabel	Blincyto blinatumomab
clgo:alternativeName	Blincyto
clgo:bioavailability	100.0
clgo:casNumber	853426-35-4
clgo:drugbank	DB09052
clgo:fdaUniiCode	4FR53SIF3A
clgo:kegg	D09325
clgo:medlinePlus	a614061
is clgo:product of	Amgen

About: clgr:Blinatumomab